Haibo Wang Selected Research

Facial Paralysis (Facial Palsy)

8/2022	The Alterations and Significance of Intercellular Adhesion Molecule-1 in Mouse Brainstem During Herpes Simplex Virus Type 1-Induced Facial Palsy.
12/2019	Platelet-rich plasma can release nutrient factors to promote facial nerve crush injury recovery in rats.
1/2015	The alteration of SHARPIN expression in the mouse brainstem during herpes simplex virus 1-induced facial palsy.
2/2014	The expression of IL-2 and IL-4 in CD4(+) T cells from mouse lymph nodes and spleen during HSV-1-induced facial palsy.
11/2013	The alterations of matrix metalloproteinase-9 in mouse brainstem during herpes simplex virus type 1-induced facial palsy.
4/2012	The alterations of inducible nitric oxide synthase in the mouse brainstem during herpes simplex virus type 1-induced facial palsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haibo Wang Research Topics

Disease

119	Neoplasms (Cancer) 03/2022 - 01/2003
41	Breast Neoplasms (Breast Cancer) 12/2022 - 05/2011
31	Neoplasm Metastasis (Metastasis) 06/2022 - 11/2008
25	Hearing Loss (Hearing Impairment) 02/2022 - 11/2011
19	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2016
18	Inflammation (Inflammations) 01/2022 - 05/2008
16	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 01/2011
15	Infections 01/2021 - 09/2008
13	Sensorineural Hearing Loss 01/2022 - 01/2013
12	Choroidal Neovascularization 01/2021 - 01/2011
11	Meniere Disease (Menieres Disease) 01/2022 - 10/2003
11	Carcinoma (Carcinomatosis) 01/2022 - 05/2009
11	Ototoxicity 01/2022 - 06/2016
10	Carcinogenesis 01/2022 - 01/2015
9	Vertigo (Positional Vertigo) 01/2022 - 10/2003
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2012
9	Hypoxia (Hypoxemia) 01/2022 - 08/2009
9	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2013
8	Vaccinia 01/2018 - 05/2005
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2010
7	Lymphatic Metastasis 11/2021 - 03/2011
7	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 10/2011
7	Deafness (Deaf Mutism) 01/2021 - 01/2014
6	Facial Paralysis (Facial Palsy) 08/2022 - 04/2012
6	Liver Neoplasms (Liver Cancer) 01/2022 - 11/2013
6	Rhinosinusitis 07/2016 - 08/2008
5	Hemorrhage 01/2022 - 02/2016
5	Pathologic Neovascularization 01/2022 - 02/2014
5	Obesity 12/2021 - 01/2012
5	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018 - 05/2011
4	Triple Negative Breast Neoplasms 03/2022 - 05/2015
4	Hypertension (High Blood Pressure) 02/2022 - 01/2020
4	Septic Shock (Toxic Shock Syndrome) 01/2022 - 08/2008
4	COVID-19 01/2022 - 01/2021
4	Myocardial Infarction 01/2022 - 08/2011
4	Necrosis 01/2022 - 12/2011
4	Disease Progression 08/2021 - 10/2016
4	Diabetes Mellitus 02/2021 - 11/2015
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 10/2016
4	Body Weight (Weight, Body) 01/2020 - 09/2013

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 08/2022 - 05/2008
32	Pharmaceutical PreparationsIBA 08/2022 - 03/2009
17	MicellesIBA 12/2021 - 08/2013
16	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 08/2011
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2011
15	Small Interfering RNA (siRNA)IBA 03/2022 - 01/2009
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
13	Messenger RNA (mRNA)IBA 01/2021 - 05/2008
11	Biological ProductsIBA 06/2022 - 05/2005
11	VaccinesIBA 01/2022 - 05/2005
11	ProdrugsIBA 08/2021 - 01/2003
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2009
10	Therapeutic UsesIBA 08/2022 - 05/2010
9	EnzymesIBA 01/2022 - 08/2008
9	Retinaldehyde (Retinal)IBA 01/2020 - 03/2012
8	Oxygen (Dioxygen)IBA 01/2018 - 01/2011
7	CytokinesIBA 03/2022 - 01/2013
7	Estrogen ReceptorsIBA 01/2022 - 08/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 04/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2008
6	GlucocorticoidsIBA 08/2022 - 11/2011
6	Matrix Metalloproteinases (MMPs)IBA 06/2022 - 01/2012
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 04/2009
5	ethyl acetateIBA 08/2022 - 06/2017
5	AcidsIBA 06/2022 - 05/2016
5	Hormones (Hormone)IBA 08/2021 - 01/2013
5	LigandsIBA 06/2021 - 10/2010
5	LipidsIBA 01/2021 - 04/2013
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 05/2008
5	Phosphotransferases (Kinase)IBA 01/2020 - 10/2012
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015 - 08/2011
5	Illicit Drugs (Recreational Drugs)IBA 01/2013 - 03/2009
4	Cadherins (E-Cadherin)IBA 06/2022 - 12/2011
4	Immunoglobulin E (IgE)IBA 01/2022 - 01/2013
4	Erythropoietin FDA Link 01/2022 - 01/2016
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2011
4	nitronyl nitroxideIBA 01/2022 - 09/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2015
4	CateninsIBA 11/2021 - 01/2016
4	Immunoglobulin G (IgG)IBA 07/2021 - 01/2013
4	AntigensIBA 01/2021 - 07/2013
4	Gentamicins (Gentamicin)FDA LinkGeneric 01/2021 - 09/2010
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 04/2013
4	PolymersIBA 04/2020 - 10/2015
4	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2010
4	NucleotidesIBA 01/2020 - 03/2016
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 10/2016
4	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2016

Therapy/Procedure

68	Therapeutics 03/2022 - 01/2009
17	Drug Therapy (Chemotherapy) 01/2022 - 04/2009
11	Lasers (Laser) 03/2022 - 01/2011
7	Neoadjuvant Therapy 07/2022 - 04/2015
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 06/2017
5	Length of Stay 08/2022 - 04/2015
5	Radiotherapy 01/2022 - 10/2010
5	Precision Medicine 04/2020 - 01/2016
5	Decompression 07/2019 - 10/2003
4	Immunotherapy 03/2022 - 11/2014
4	Operative Surgical Procedures 01/2022 - 09/2015